Showing results (2151-2160 of 6,777) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|April 22, 2018
The Psychiatric Consequences of CannabinoidsJoao P De Aquino, Mohamed Sherif, Rajiv Radhakrishnan, et al.Clinical Therapeutics|April 3, 2018
Plasma Exchange for Neuromyelitis Optica Spectrum Disorders in Chinese Patients and Factors Predictive of Short-term OutcomeYujuan Jiao, Lei Cui, Weihe Zhang, et al.Clinical Therapeutics|January 1, 1987
Early experience with the use of anti-inhibitor coagulant complex to treat bleeding in hemophiliacs with inhibitors to factor VIIIJ L Kantrowitz, M L Lee, D A McClure, et al.Clinical Therapeutics|May 27, 2019
Association Between Exposure of Ipratropium and Salmeterol and Diagnosis of Multiple Sclerosis: A Matched Case-control StudyJinma Ren, Marisa Ascencio, Tommaso Raimondi, et al.Clinical Therapeutics|May 27, 2019
Influence of CYP450 Enzymes, CES1, PON1, ABCB1, and P2RY12 Polymorphisms on Clopidogrel Response in Patients Subjected to a Percutaneous NeurointerventionMiriam Saiz-Rodríguez, Carmen Belmonte, José Luis Caniego, et al.Clinical Therapeutics|June 17, 2019
Efficacy and Safety of Udenafil for the Treatment of Pulmonary Arterial Hypertension: a Placebo-controlled, Double-blind, Phase IIb Clinical TrialHyuk-Jae Chang, Shinjeong Song, Sung-A Chang, et al.Clinical Therapeutics|September 7, 2018
The Role of Colchicine in Acute Coronary SyndromesKaivan Vaidya, Gonzalo Martínez, Sanjay PatelClinical Therapeutics|September 7, 2018
The Safety and Antiviral Activity of BZF961 with or without Ritonavir in Patients Infected with Hepatitis C Virus: A Randomized, Multicenter TrialEric Lawitz, Mohamed Bidair, Thomas Marbury, et al.Clinical Therapeutics|July 1, 2018
Establishment of the National Consortium for Regenerative Medicine and National Regenerative Medicine Database in JapanKiyoshi Okada, Yoji Sato, Daisuke Sugiyama, et al.Clinical Therapeutics|July 16, 2018
Treatment Outcomes and Health Care Resource Utilization in Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide-only Maintenance, Any Maintenance, or No Maintenance: Results from the Connect MM RegistryRobert M Rifkin, Sundar Jagannath, Brian G M Durie, et al.Pageof 678